A detailed history of Hills Bank & Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Hills Bank & Trust CO holds 4,363 shares of BIIB stock, worth $689,397. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,363
Previous 4,350 0.3%
Holding current value
$689,397
Previous $1.01 Million 16.17%
% of portfolio
0.07%
Previous 0.08%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$189.07 - $236.8 $2,457 - $3,078
13 Added 0.3%
4,363 $845,000
Q2 2024

Jul 25, 2024

BUY
$190.52 - $236.72 $38,485 - $47,817
202 Added 4.87%
4,350 $1.01 Million
Q1 2024

May 08, 2024

BUY
$212.02 - $267.71 $27,138 - $34,266
128 Added 3.18%
4,148 $894,000
Q4 2023

Feb 07, 2024

BUY
$222.59 - $267.94 $7,345 - $8,842
33 Added 0.83%
4,020 $1.04 Million
Q3 2023

Oct 26, 2023

BUY
$253.3 - $285.89 $82,069 - $92,628
324 Added 8.85%
3,987 $1.02 Million
Q2 2023

Jul 21, 2023

BUY
$275.25 - $318.06 $56,426 - $65,202
205 Added 5.93%
3,663 $1.04 Million
Q1 2023

Apr 17, 2023

BUY
$256.56 - $292.34 $295,813 - $337,068
1,153 Added 50.02%
3,458 $961,000
Q4 2022

Feb 06, 2023

BUY
$252.44 - $306.72 $154,493 - $187,712
612 Added 36.15%
2,305 $639,000
Q3 2022

Nov 03, 2022

BUY
$194.69 - $268.46 $204,813 - $282,419
1,052 Added 164.12%
1,693 $452,000
Q2 2022

Aug 02, 2022

BUY
$187.54 - $223.02 $120,213 - $142,955
641 New
641 $130,000
Q1 2021

May 03, 2021

SELL
$242.95 - $284.63 $109,327 - $128,083
-450 Closed
0 $0
Q4 2020

Feb 01, 2021

SELL
$236.26 - $355.63 $14,411 - $21,693
-61 Reduced 11.94%
450 $110,000
Q3 2020

Oct 27, 2020

SELL
$264.77 - $305.71 $240,675 - $277,890
-909 Reduced 64.01%
511 $145,000
Q2 2020

Aug 05, 2020

SELL
$258.66 - $342.55 $153,902 - $203,817
-595 Reduced 29.53%
1,420 $380,000
Q1 2020

Apr 17, 2020

BUY
$268.85 - $341.04 $20,701 - $26,260
77 Added 3.97%
2,015 $638,000
Q4 2019

Jan 27, 2020

BUY
$220.06 - $304.07 $10,562 - $14,595
48 Added 2.54%
1,938 $575,000
Q3 2019

Oct 18, 2019

BUY
$217.44 - $243.88 $2,174 - $2,438
10 Added 0.53%
1,890 $440,000
Q2 2019

Jul 16, 2019

SELL
$219.29 - $241.72 $683,526 - $753,441
-3,117 Reduced 62.38%
1,880 $439,000
Q1 2019

Apr 17, 2019

BUY
$216.71 - $338.96 $14,302 - $22,371
66 Added 1.34%
4,997 $1.18 Million
Q4 2018

Jan 28, 2019

SELL
$278.5 - $352.75 $13,368 - $16,932
-48 Reduced 0.96%
4,931 $1.48 Million
Q3 2018

Oct 15, 2018

SELL
$293.51 - $383.83 $10,566 - $13,817
-36 Reduced 0.72%
4,979 $1.76 Million
Q2 2018

Jul 17, 2018

BUY
$257.52 - $306.91 $34,250 - $40,819
133 Added 2.72%
5,015 $1.46 Million
Q1 2018

Apr 13, 2018

BUY
$260.13 - $367.91 $19,509 - $27,593
75 Added 1.56%
4,882 $1.34 Million
Q4 2017

Jan 16, 2018

SELL
$307.64 - $344.58 $5,229 - $5,857
-17 Reduced 0.35%
4,807 $1.53 Million
Q3 2017

Oct 16, 2017

BUY
$281.15 - $329.69 $1.36 Million - $1.59 Million
4,824
4,824 $1.51 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Hills Bank & Trust CO Portfolio

Follow Hills Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hills Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Hills Bank & Trust CO with notifications on news.